Amanote Research
Register
Sign In
Cediranib in Glioblastoma
doi 10.2174/978160805132811001010176
Full Text
Open PDF
Abstract
Available in
full text
Date
March 28, 2012
Authors
Elizabeth R. Gerstner
Jorg H. Dietrich
Daphne Wang
Tracy T. Batchelor
Publisher
BENTHAM SCIENCE PUBLISHERS
Related search
Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma
Cancer Research
Cancer Research
Oncology
Cediranib Is Effective in Alveolar Soft Part Sarcoma
Cancer Discovery
Oncology
Phase II Study of Cediranib in Patients With Malignant Pleural Mesothelioma: SWOG S0509
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MicroRNAs in Cancer: Glioblastoma and Glioblastoma Cancer Stem Cells
Neurochemistry International
Molecular Neuroscience
Cell Biology
Cellular
Immunological Evasion in Glioblastoma
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Ion Channels in Glioblastoma
ISRN Neurology
Cediranib With mFOLFOX6 vs Bevacizumab With mFOLFOX6 in Previously Treated Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Faculty Opinions Recommendation of Cediranib for Metastatic Alveolar Soft Part Sarcoma.
Glioblastoma in 140 Characters
Neurology
Neurology